STEPHANIE BYRNE: Open Payments
NPI 1386192300 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,723 in 146 payments from 21 companies in 2025. Trend: 2023 $2,732 · 2024 $3,632 · 2025 $2,723
Food & beverage: $2,611Education: $112
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 19 | $634 |
| Galderma Laboratories, L.P. | 22 | $315 |
| Amgen Inc. | 12 | $257 |
| Janssen Biotech, Inc. | 16 | $252 |
| ABBVIE INC. | 26 | $232 |
| Arcutis Biotherapeutics, Inc. | 10 | $219 |
| GENZYME CORPORATION | 13 | $185 |
| UCB, Inc. | 5 | $127 |
| Lilly USA, LLC | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
Products named: ILUMYA, OTEZLA, NEMLUVIO, TREMFYA, Zoryve, DUPIXENT, SKYRIZI, Bimzelx.
Industry payments across KY — which companies pay providers there.
